Sfoglia per Autore
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy
2021-01-01 Cosentini, D.; Grisanti, S.; Lagana, M.; Ferrari, V. D.; Volta, A. D.; Sigala, S.; Terzolo, M.; Berruti, A.
Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy
2021-01-01 Grisanti, S.; Cosentini, D.; Lagana, M.; Morandi, A.; Lazzari, B.; Ferrari, L.; Volta, A. D.; Ambrosini, R.; Ferrari, V. D.; Sigala, S.; Berruti, A.
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma
2021-01-01 Cosentini, D.; Turla, A.; Carminati, O.; Grisanti, S.; Ferrari, V. D.; Lagana, M.; Rosti, G.; Sigala, S.; Berruti, A.
Maintenance everolimus beyond progression in pancreatic NET to control insulinoma syndrome
2021-01-01 Tovazzi, V.; Ferrari, V. D.; Berruti, A.
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma
2022-01-01 Lagana, M.; Grisanti, S.; Ambrosini, R.; Cosentini, D.; Abate, A.; Zamparini, M.; Ferrari, V. D.; Gianoncelli, A.; Turla, A.; Canu, L.; Terzolo, M.; Tiberio, G. A. M.; Sigala, S.; Berruti, A.
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen
2022-01-01 Turla, Antonella; Lagana, Marta; Grisanti, Salvatore; Abate, Andrea; Ferrari, Vittorio Domenico; Cremaschi, Valentina; Sigala, Sandra; Consoli, Francesca; Cosentini, Deborah; Berruti, Alfredo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy | 1-gen-2021 | Cosentini, D.; Grisanti, S.; Lagana, M.; Ferrari, V. D.; Volta, A. D.; Sigala, S.; Terzolo, M.; Berruti, A. | |
| Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy | 1-gen-2021 | Grisanti, S.; Cosentini, D.; Lagana, M.; Morandi, A.; Lazzari, B.; Ferrari, L.; Volta, A. D.; Ambrosini, R.; Ferrari, V. D.; Sigala, S.; Berruti, A. | |
| Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma | 1-gen-2021 | Cosentini, D.; Turla, A.; Carminati, O.; Grisanti, S.; Ferrari, V. D.; Lagana, M.; Rosti, G.; Sigala, S.; Berruti, A. | |
| Maintenance everolimus beyond progression in pancreatic NET to control insulinoma syndrome | 1-gen-2021 | Tovazzi, V.; Ferrari, V. D.; Berruti, A. | |
| Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma | 1-gen-2022 | Lagana, M.; Grisanti, S.; Ambrosini, R.; Cosentini, D.; Abate, A.; Zamparini, M.; Ferrari, V. D.; Gianoncelli, A.; Turla, A.; Canu, L.; Terzolo, M.; Tiberio, G. A. M.; Sigala, S.; Berruti, A. | |
| Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen | 1-gen-2022 | Turla, Antonella; Lagana, Marta; Grisanti, Salvatore; Abate, Andrea; Ferrari, Vittorio Domenico; Cremaschi, Valentina; Sigala, Sandra; Consoli, Francesca; Cosentini, Deborah; Berruti, Alfredo |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile